Back to Rare Disease
This trial is complete. It is no longer accepting participants.

NCT00004658

NCT00004658
Completed Phase 2

Who may be able to join

Who might be able to join this trial:

  • You have a complex condition where certain skin cells show too much activity of a specific enzyme called 5'-nucleotidase (confirm with trial site)
  • You experience repeated or frequent infections
  • You have a seizure disorder (epilepsy)
  • You have difficulty with speech or communication
  • You have attention difficulties or behavioral challenges

Who may not be able to join:

  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 2
Sponsor
National Center for Research Resources (NCRR)
Registry
clinicaltrials_gov
Start date
1 March 1995

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov